Midwest Business Group on Health Employer Survey on Biologics/Specialty Pharmacy

Advances in biotechnology have led to the development of new medical therapies for a variety of diseases. Among these advances is a category of medications called specialty drugs, which include biologics that treat life-threatening diseases like cancer, hemophilia and HIV/AIDS, and complex chronic conditions like rheumatoid arthritis and multiple sclerosis.

It’s predicted that in the next 5 to 8 years, specialty drugs will represent approximately 40% of all pharmacy benefits spend. Not only are drugs in this category very expensive but they are also being produced for a rising number of complex and chronic conditions, with a very robust pipeline.

The Midwest Business Group on Health (an NBCH sister coalition) is conducting an employer research project focused on helping employers better understand and manage this challenging benefit, and learn which approaches to benefit plan design and vendor management and contracting are optimal for their organization and employee population.

MBGH will do its best to pull out a report specific to the employers who completed the survey based on the state they indicate they are located. Regardless, all coalitions who participate will receive a copy of the final report.

The survey completion deadline is Monday, October 8th. Respondents who provide their contact information will receive a copy of the survey results. Respondents who complete the entire survey will be eligible to win one of five $100 gift cards!

Click on this link to complete the survey: Specialty Pharmacy Survey  (Please note, there are TWO PAGES to the survey and it’s important that you complete ALL of the questions.)